TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Morin, Auranofin
Phytochemical Name Morin (PubChem CID: 5281670 )
Anticancer drug Name Auranofin (PubChem CID: 24199313 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 116
Pair Name Morin, Auranofin
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Induction-->ROS generation
Gene Regulation Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Down-regulation Expression BIRC2 hsa329
Down-regulation Expression BIRC3 hsa330
Down-regulation Expression CASP3 hsa836
Down-regulation Expression CASP8 hsa841
Down-regulation Expression CASP9 hsa842
Up-regulation Expression CYCS hsa54205
Up-regulation Cleavage PARP1 hsa142
Up-regulation Expression TNFRSF10A hsa8797
Up-regulation Expression TNFRSF10B hsa8795
Down-regulation Expression XIAP hsa331
In Vitro Model Hep 3B2.1-7 Childhood hepatocellular carcinoma Homo sapiens (Human) CVCL_0326
Result This study provides evidence that morin can enhance the anticancer activity of AF in Hep3B human hepatocellular carcinoma cells, indicating that its combination could be an alternative treatment strategy for the hepatocellular carcinoma.
03. Reference
No. Title Href
1 Morin enhances auranofin anticancer activity by up-regulation of DR4 and DR5 and modulation of Bcl-2 through reactive oxygen species generation in Hep3B human hepatocellular carcinoma cells. Phytother Res. 2019 May;33(5):1384-1393. doi: 10.1002/ptr.6329. Click
It has been 47009 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP